Published in Hepatology on March 01, 2002
Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol (2006) 4.34
Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci (2006) 1.50
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg (2005) 1.21
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20
Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials. Crit Care (2015) 1.07
Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol (2013) 1.05
Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations. Hepatol Int (2011) 1.04
Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol (2013) 1.03
Management of varices in patients with cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 0.99
Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for nonseptic ICU patients. Crit Care (2015) 0.97
Cirrhosis and its complications: evidence based treatment. World J Gastroenterol (2014) 0.93
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Emergency management of bleeding esophageal varices: drugs, bands or sleep? Can J Gastroenterol (2006) 0.92
Predictors of a variceal source among patients presenting with upper gastrointestinal bleeding. Can J Gastroenterol (2012) 0.92
An assessment of endoscopic and concomitant management of acute variceal bleeding at a tertiary care centre. Can J Gastroenterol (2007) 0.91
Systematic review and meta-analysis of the clinical efficacy and adverse effects of Chinese herbal decoction for the treatment of gout. PLoS One (2014) 0.90
Management of portal hypertension. Postgrad Med J (2004) 0.90
Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a swiss multicentric cohort. Case Rep Gastroenterol (2013) 0.89
Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol (2010) 0.87
Effect on quality of life of continuous positive airway pressure in patients with obstructive sleep apnea syndrome: a meta-analysis. Lung (2008) 0.86
Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis. World J Gastroenterol (2011) 0.86
Management of portal hypertension in children. World J Gastroenterol (2012) 0.85
Characteristics and outcomes of acute upper gastrointestinal bleeding after therapeutic endoscopy in the elderly. World J Gastroenterol (2011) 0.85
Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int Orthop (2015) 0.85
Transvaginal cholecystectomy vs conventional laparoscopic cholecystectomy for gallbladder disease: A meta-analysis. World J Gastroenterol (2015) 0.84
Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage. Int J Hepatol (2011) 0.84
Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol (2014) 0.84
Use of portal pressure studies in the management of variceal haemorrhage. World J Gastrointest Endosc (2012) 0.83
Self-Expanding Metal Stent (SEMS): an innovative rescue therapy for refractory acute variceal bleeding. Endosc Int Open (2014) 0.82
Evolution of endoscopic therapy for esophageal varices. Surg Endosc (2006) 0.82
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
Therapeutic and prophylactic management of bleeding from oesophageal and gastric varices - recommendations of the Working Group of the National Consultant for Gastroenterology. Prz Gastroenterol (2014) 0.80
Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepat Med (2011) 0.78
Prevention and management of variceal hemorrhage. Int J Hepatol (2013) 0.78
Prevention and management of gastroesophageal varices in cirrhosis. Int J Hepatol (2012) 0.78
Pharmacological Treatment in Upper Gastrointestinal Bleeding. Curr Treat Options Gastroenterol (2015) 0.78
When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS? Langenbecks Arch Surg (2003) 0.78
General aspects of the treatment of alcoholic hepatitis. World J Hepatol (2011) 0.77
Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin? Crit Care (2006) 0.77
Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf) (2017) 0.76
Meta-analysis of trials for variceal bleeding. Hepatology (2002) 0.76
Endoscopic management of portal hypertension. Int J Hepatol (2012) 0.76
Management of upper gastrointestinal bleeding from portal hypertension: Elective or emergency operation? Pak J Med Sci (2014) 0.75
Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension. ISRN Hepatol (2013) 0.75
Acute variceal hemorrhage in patients with liver cirrhosis: weekend versus weekday admissions. Yonsei Med J (2012) 0.75
Sucralfate and Lidocain: Antacid 50:50 solution in Post Esophageal Variceal Band Ligation Pain. Pak J Med Sci (2016) 0.75
Addition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial. J Clin Exp Hepatol (2015) 0.75
Efficacy and safety of Chinese herbal medicine for chronic prostatitis associated with damp-heat and blood-stasis syndromes: a meta-analysis and literature review. Patient Prefer Adherence (2016) 0.75
Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis. Biomed Res Int (2016) 0.75
Superior Mesenteric Arteriovenous Fistula Presenting with Massive Lethal Upper Gastrointestinal Bleeding 14 Years after Small Bowel Resection. Balkan Med J (2015) 0.75
Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis. BMC Cancer (2015) 0.75
Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin North Am (2014) 0.75
Self-expandable metallic stents for bleeding esophageal varices. Saudi J Gastroenterol (2013) 0.75
Role of endoscopy in management of gastrointestinal complications of portal hypertension. World J Gastrointest Endosc (2015) 0.75
Therapeutic potential of targeting the renin angiotensin system in portal hypertension. World J Gastrointest Pathophysiol (2013) 0.75
TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update. J Huazhong Univ Sci Technolog Med Sci (2017) 0.75
Colorectal adenoma recurrence rates among post-polypectomy patients in the placebo-controlled groups of randomized clinical trials: a meta-analysis. Oncotarget (2017) 0.75
Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1. Dig Dis Sci (2007) 0.75
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol (2012) 4.62
Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA (2013) 4.18
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology (2003) 3.66
A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol (2008) 2.35
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology (2013) 2.08
Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med (2008) 2.05
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology (2004) 2.01
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology (2003) 1.91
A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol (2005) 1.73
Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response. Am J Gastroenterol (2010) 1.59
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology (2004) 1.55
Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transpl (2012) 1.53
Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms. Transplantation (2007) 1.51
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology (2002) 1.30
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology (2008) 1.26
Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology (2005) 1.22
Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period. J Hepatol (2012) 1.17
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation. Liver Transpl (2012) 1.16
Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transpl (2009) 1.13
Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. FEBS Lett (2005) 1.11
Antibodies to selected viral and bacterial pathogens in European wild boars from southcentral Spain. J Wildl Dis (2002) 1.09
Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int (2003) 1.05
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. J Hepatol (2008) 1.05
Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am J Gastroenterol (2006) 0.97
Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol (2007) 0.95
Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology (2002) 0.94
Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter. BMC Mol Biol (2006) 0.94
Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol (2008) 0.93
The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis. Gut (2006) 0.91
Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease. Clin Diagn Lab Immunol (2002) 0.90
Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis. Liver Int (2008) 0.90
Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis. Hepatology (2010) 0.89
Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis. Hepatology (2012) 0.88
HPV Direct Flow CHIP: a new human papillomavirus genotyping method based on direct PCR from crude-cell extracts. J Virol Methods (2013) 0.87
Oral leiomyoma: a case report. Med Oral (2003) 0.86
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. J Pediatr (2006) 0.86
Blood lead and cadmium levels in a six hospital employee population. PESA study, 2009. J Trace Elem Med Biol (2010) 0.86
Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis. Scand J Gastroenterol (2012) 0.85
Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis. Scand J Gastroenterol (2012) 0.84
Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation (2008) 0.84
Disruption of the Cys5-Cys7 disulfide bridge in the platelet glycoprotein Ibbeta prevents the normal maturation and surface exposure of GPIb-IX complexes. Thromb Haemost (2003) 0.84
Multifactorial gut barrier failure in cirrhosis and bacterial translocation: working out the role of probiotics and antioxidants. J Hepatol (2002) 0.83
Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. J Clin Pharmacol (2013) 0.83
Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation. Liver Transpl (2009) 0.83
Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites. Liver Int (2014) 0.83
Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma. Scand J Gastroenterol (2012) 0.82
Mesenteric Th1 polarization and monocyte TNF-alpha production: first steps to systemic inflammation in rats with cirrhosis. Hepatology (2005) 0.82
Activation of phospholipase D-2 by P2X(7) agonists in rat submandibular gland acini. J Lipid Res (2002) 0.81
[Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival]. Gastroenterol Hepatol (2009) 0.80
Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography. Clin Infect Dis (2013) 0.80
A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors. Thromb Haemost (2004) 0.80
Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation. Transplantation (2007) 0.79
Systemic effects of TNF-alpha secreted by circulating monocytes and fatigue in cirrhosis. Hepatology (2006) 0.78
Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis? Med Hypotheses (2013) 0.78
Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation. Transplantation (2016) 0.77
Labour productivity losses caused by premature death associated with hepatitis C in Spain. Eur J Gastroenterol Hepatol (2015) 0.77
Relationship between response to interferon-alpha and function of peripheral blood mononuclear cells in chronic hepatitis C patients. Dig Dis Sci (2002) 0.77
Quantitative profile of lipid classes in blood by normal phase chromatography with evaporative light scattering detector: application in the detection of lipid class abnormalities in liver cirrhosis. Clin Chim Acta (2013) 0.77
Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis. J Hepatol (2013) 0.77
Portal hypertensive colopathy is associated with portal hypertension severity in cirrhotic patients. World J Gastroenterol (2009) 0.76
Systemic inflammation in absence of gut bacterial translocation in C57BL/6 mice with cirrhosis. Gut (2012) 0.76
Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection. Rev Esp Quimioter (2013) 0.76
Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement. Dis Markers (2011) 0.75
[Liver transplantation in patients with HIV infection: a reality in 2004]. Enferm Infecc Microbiol Clin (2004) 0.75
Detection and Genotyping of Human Papillomavirus DNA in Formalin-Fixed Paraffin-Embedded Specimens with the HPV Direct Flow CHIP System. Open Virol J (2013) 0.75
Do we use more NGT than needed? Dig Dis Sci (2014) 0.75
Which is the best way to analyze the efficacy of albumin dialysis in hepatic encephalopathy? Hepatology (2008) 0.75
Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation. Transplantation (2016) 0.75
N-type calcium channels mediate a GABA(B) presynaptic modulation in the corticostriatal synapse in turtle's paleostriatum augmentatum. Synapse (2009) 0.75
Does interferon improve portal hypertension? J Antimicrob Chemother (2006) 0.75
Non granular laterally spreading tumor resected by endoscopic submucosal dissection: An unusual treatment for an atypical lesion. Rev Esp Enferm Dig (2013) 0.75
Effect of Eradication of HCV on Hepatic Venous Pressure Gradient in HIV-Infected Patients With Compensated HCV-Related Cirrhosis. J Acquir Immune Defic Syndr (2015) 0.75
Polypharmacy in Patients With Inflammatory Bowel Disease: Prevalence and Outcomes in a Single-center Series. J Clin Gastroenterol (2022) 0.75
Study of neuron survival on polypyrrole-embedded single-walled carbon nanotube substrates for long-term growth conditions. J Biomed Mater Res A (2014) 0.75
Influence of air oxidation on the surfactant-assisted purification of single-walled carbon nanotubes. Langmuir (2011) 0.75
[Innovations in the epidemiology, natural history, diagnosis and treatment of sleep apnea-hypopnea syndrome]. Arch Bronconeumol (2009) 0.75
Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension. Liver Int (2014) 0.75
Chemometric studies of chemical compounds in five cultivars of potatoes from Tenerife. J Agric Food Chem (2002) 0.75
[Liver diseases]. Gastroenterol Hepatol (2008) 0.75
[Epidemiological surveillance: a challenge for occupational health]. Arch Prev Riesgos Labor (2013) 0.75
alpha-Adrenergic-mediated activation of human reconstituted fibrinogen receptor (integrin alphaIIbbeta3) in Chinese hamster ovary cells. Thromb Haemost (2004) 0.75
Color quality of pigments in cochineals (Dactylopius coccus Costa). Geographical origin characterization using multivariate statistical analysis. J Agric Food Chem (2004) 0.75
[Portal hypertension: recommendations for evaluation and treatment: consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases(CIBERehd)]. Gastroenterol Hepatol (2012) 0.75
Improving the efficiency of antioxidant extraction from mango peel by using microwave-assisted extraction. Plant Foods Hum Nutr (2013) 0.75